Christopher Granger

@0IvankaTrumpRV2 Zero

Simple poll. Please be honest! As of today, how much do you still trust this team? A. 100% B. 75% C. 50% D. 25% E. 0%

@loganncampbelll Wow even a few minutes would be great!

No boot for Caleb Foster. Jon Scheyer said that the starting guard will try to play on Friday against St. John’s.

@hvanspall @krychtiukmd @jspertus @thiele_holger @BradiGranger @AHAScience @AHAMeetings @manesh_patelMD @DukeHFDoc @robmentz Thank you SO much Harriette ! I love the pictures !

So proud of my friend, Prof Christopher Granger, who will receive James B. Herrick Award from our Council on Clinical Cardiology at #AHA25 for scientific achievements that have advanced the practice of cardiology. Stellar trialist, friend, mentor to many! professional.heart.org/en/meetings/sc…

When cardiovascular medicines should be discontinued - for the prevention of potential harm - for a lack of benefit - for the availability of better alternatives. Our #deprescribing review has just been published in @ESC_Journals @cbgranger @DCRINews doi.org/10.1093/eurhea…

@thiele_holger @hvanspall @manesh_patelMD Thanks for the great visit from all in Durham !

Thank you for inviting me! Really enjoyed the stay and to see your impressive cardiology department and team including the rooster 🐔 @hvanspall @cbgranger @manesh_patelMD

Tour de force @DukeCardiology Grand Rounds by @thiele_holger on “Cardiogenic Shock Treatment- Between Clinical Practice and Current Evidence.” @DukeHeartCenter @DukeHrtFailure @DukeMedSchool @manesh_patelMD @JasonKatzMD @jennifer_rymer @Nishant_ShahMD

Fantastic talk! Itd all about the first 10 minutes!

ACC 23 Late-breaking Discussion with @NPagidipati & @cbgranger:COORDINATE-Diabetes Trial Multifaceted intervention⬆️prescription of 3 groups of evidence-based therapies Publication: ja.ma/3ZkfIbM #LBCT #ACC23 #WCCardio #laSECtelleva #DIabetes youtu.be/LxXeTg0SBdY

#ACC23 🔥Late-breaking Discussion Join Drs @hvanspall, @NPagidipati & @cbgranger as they discuss the #COORDINATE-Diabetes trial👉 ow.ly/9iij50N9Ftu Coordinated, multifaceted intervention ⬆️ prescription of 3 groups of evidence-based therapies in adults with #T2DM & #ASCVD

Learning about so many exciting advances in #HeartFailure at the #BeaverCreekCardiovascular conference. #HFGuidelines #cardiacamyloid new devices #xenotransplantation and more! @robmentz @DukeCardiology @BeaumontCards

@dranulala @hvanspall @AnnalsofIM @robmentz @DrMarthaGulati @AndrewJSauer @AshishCorrea @PamTaubMD @JeffTeuteberg @amorrismd @MelvinEchols9 @BiykemB @DrQuinnCapers4 Couldn’t agree more. “Signing out AMA” is an anachronism.

This. #WordsMatter 👇🏽 🚫Against Medical Advice (AMA) -stigmatizing, depersonalized, antagonistic relationship w/patients ✅ Before Medically Advised (BMA) -promotes curiosity to understand patient circumstances, set up for better patient-clinician communication @AnnalsofIM

RNA-targeted therapeutics in CVD: the time is now! We tried to provide an update on several exciting developments in the field of RNA-targeted therapeutics in CVD - focus on lipids, anticoagulation, TTR amyloidosis and hypertension. #siRNA #ASO academic.oup.com/ehjcvp/advance…

Go @CVCTForum!

We just made it! #ECLS-SHOCK last patient in just happened!!! Congrats to the whole team! Another milestone in #cardiogenicshock treatment! ⁦@AGIKinterv⁩ ⁦@KardiologieHH⁩ ⁦@TRassafMD⁩ ⁦@YoungDgk⁩ ⁦@DGK_org⁩ ⁦@AnneFreund3⁩ ⁦⁦@hvanspall⁩

Time to treatment in STEMI is critical and we are not meeting our goals! We need to refocus efforts! ja.ma/3zO4Zf7 via @JAMA_current part of @JAMANetwork. Congrats to Dr Jamie Jollis & @cbgranger @AKjacobsBUMC on this study. Proud to be part of such an amazing team!

Just arrived in Chicago for #AHA22. Easy trip from Durham & nice to catch up w friends in the Uber. Caught a glimpse of @DCRINews booth. Early checkin & time for a run before meetings start @AHAScience @cbgranger @manesh_patelMD @DukeHeartCenter